Navigation Links
Gel Shows Promise as Future Male Contraceptive
Date:7/2/2012

By Amanda Gardner
HealthDay Reporter

MONDAY, July 2 (HealthDay News) -- Men may one day have a birth-control option other than the condom or vasectomy -- if early research on a new contraceptive gel pans out.

Preliminary findings suggest that when applied to the skin, the gel dramatically lowers sperm counts, thus also lowering -- though not eliminating -- the risk for pregnancy.

This is the first time that a combination of testosterone and a synthetic progestin called Nestorone has been tested as a gel that could be applied topically. Previous research involved administering the combination by injection or via a patch, said study senior author Dr. Christina Wang, a professor of medicine at Los Angeles Biomedical Research Institute.

The combination contraceptive needs to undergo further testing before it is commercially available.

Although men have sometimes received a bad rap for not being willing to assume responsibility for birth control, Dr. Joseph Alukal, an assistant professor of urology at NYU Langone Medical Center, in New York City, thinks this reputation may be somewhat undeserved.

"I think [men] would use it more than is realized," said Alukal, who was not involved in the new research. "Plenty of guys are concerned about unwanted pregnancy, almost as much as women."

Unfortunately, condoms and vasectomy have remained the only commercially available contraception options for men.

The results of the study, funded by the U.S. National Institutes of Child Health and Human Development, were presented at the recent Endocrine Society annual meeting, held in Houston.

According to Wang, the gel was applied in two spots -- the testosterone component on the arm and the progestin component on the abdomen. The gels were applied every day for six months.

The study, conducted in conjunction with the University of Washington, involved 56 men who were assigned to receive one of three types of gels: one gel containing both testosterone plus a gel containing one of two doses of the synthetic progestin; or a gel containing testosterone on its own plus a "placebo" gel with no progestin.

Up to 89 percent of the men who received the combination formulas saw their sperm concentrations plunge to less than 1 million sperm per milliliter, versus just 23 percent of those receiving only testosterone.

Normal sperm concentration is more than 15 million sperm per milliliter, according to the Mayo Clinic's website.

Up to 78 percent of men receiving the drug combination in the study saw their concentrations drop to no sperm at all, versus only 23 percent of men taking testosterone alone.

The testosterone/progestin combination works by shutting off the hormones that control production of sperm in the testes, Wang explained.

One important and unanswered question is what the long-term side effects of this regimen might be.

The answer, said Wang, is "We just don't know."

That's apart from mild-to-moderate acne or an increase in acne, which was seen in about 21 percent of participants.

A new formulation currently being developed that contains half the amount of testosterone might decrease or eliminate that problem, Wang speculated.

Another question is how reversible this would be in terms of restoring sperm counts, Alukal said.

In addition to planning more studies on this combination protocol, Wang is also in early phases of testing the male hormone dimethandrolone, which is more potent than testosterone.

Because the new study was presented at a medical meeting, the data and conclusions should be viewed as preliminary until published in a peer-reviewed journal.

More information

There's more on contraception at the American College of Obstetricians and Gynecologists.

SOURCES: Christina Wang, M.D., professor of medicine, Los Angeles Biomedical Research Institute; Joseph P. Alukal, M.D., assistant professor of urology, NYU Langone Medical Center, New York City; presentation, Endocrine Society annual meeting, June 23-26, Houston


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. UT Southwestern study shows treating diabetes early, intensively is best strategy
2. Glucose deprivation activates feedback loop that kills cancer cells, UCLA study shows
3. Genome-wide analysis shows previously undetected abnormalities in parents of affected children
4. Myelodysplastic syndrome treated with deferasirox shows beneficial iron reduction, Moffitt says
5. Autism Speaks provides strategies to help a child with autism shows difficult behaviors
6. Study shows stagnating life expectancies in US
7. UW research shows new prognosis tool for deadly brain cancer
8. Stanford study shows opiates side effects rooted in patients genetics
9. Study shows no evidence medical marijuana increases teen drug use
10. State Laws Cut Teen Drinking and Driving, Large Study Shows
11. Quality of life study shows stereotactic ablative radiotherapy effective treatment; stage I NSCLC
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gel Shows Promise as Future Male Contraceptive
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: